开发和物理稳定性评估,即时配方的 gabapentin 片
Marisol López-Nieves1, Jetzabel Delgado-Díaz2, Sormarie Figueroa-Morales2
1University of Puerto Rico School of Pharmacy, Medical Sciences Campus, Trujillo Alto, PR. marisol.lopez@upr.edu.
International journal of pharmaceutical compounding
|October 20, 2025
概括
gabapentin 药片为患者提供了一个稳定的替代品,特别是老年人. 软 (PEG) 和可 (凝) 基在室温下稳定,而硬 (醇) 和软 (PEG) 基在冷藏下稳定.
科学领域:
- 制药科学 制药科学
- 药物的配方 药物的配方
- 复合药房 复合药房 复合药房
背景情况:
- 药片配方可用于局部或全身药物输送,帮助患有食障碍的患者.
- 加巴丁经常被处方给老年人,突出需要替代剂型.
- 对特定患者群体来说,加巴丁药片的随机组合是一个有价值的选择.
研究的目的:
- 用三个不同的基础开发和评估 gabapentin 药片.
- 为了确定一个物理稳定的临时 gabapentin 配方的最佳基础.
主要方法:
- 三种 gabapentin 片配方使用sorbitol (硬),PEG (软) 和凝 (可咬) 基准备.
- 物理稳定性在4°C和25°C的8周内被评估.
- 测试包括外观,重量变化和溶解,以评估配方完整性.
主要成果:
- 加巴丁在室温 (25°C) 的软 (PEG) 和可 (凝) 基中表现出物理稳定性.
- 硬 (醇) 和软 (PEG) gabapentin 片配方在冷藏 (4°C) 时保持稳定.
结论:
- 用软 (PEG) 和可 (凝) 基制成的 gabapentin 软片在室温下是可行的.
- 硬 (醇) 和软 (PEG) gabapentin 药片配方适合冷藏储存.
- 这些稳定的配方代表了对 gabapentin 输送的有希望的新剂量形式.
相关概念视频
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
303
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
303
Drug Product Stability
223
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
223
Factors Influencing Drug Absorption: Pharmaceutical Parameters
396
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
396
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
177
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
177
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
Drug Dissolution: Requirements and Profile Comparison
236
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
236


